Product Details:
| Manufacturer | BDR |
| Packaging Size | 112 capsule |
| Brand | BDenza |
| Composition | Enzalutamide 40mg |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Therapeutic Uses | prostate cancer |
| Treatment | Prostate Cancer |
| Country of Origin | Made in India |
Pharmaceutical Tablet & Capsules
BDenza 40mg Enzalutamide BDR
₹15,000.00
Enzalutamide is approved by the FDA for the treatment of men with metastatic castrate-resistant prostate cancer that is no longer responding to chemotherapy. However, chemotherapy is not a treatment option for many men with pre-existing medical conditions or who cannot tolerate the side effects
Related products
-
Palbociclib Palbace 75Mg 100mg Capsule
₹67,000.00 -
Posaconazole Suspension Pocozole
₹5,500.00
Reviews
There are no reviews yet.